Search International and National Patent Collections
Some content of this application is unavailable at the moment.
If this situation persist, please contact us atFeedback&Contact
1. (WO1997016193) PHARMACEUTICAL COMPOSITION FOR TREATING OSTEOPOROSIS
Latest bibliographic data on file with the International Bureau

Pub. No.: WO/1997/016193 International Application No.: PCT/EP1996/004532
Publication Date: 09.05.1997 International Filing Date: 18.10.1996
Chapter 2 Demand Filed: 19.04.1997
IPC:
A61K 31/59 (2006.01)
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31
Medicinal preparations containing organic active ingredients
59
Compounds containing 9,10-seco-cyclopenta[a]hydro- phenanthrene ring systems
Applicants:
F. HOFFMANN-LA ROCHE AG [CH/CH]; Grenzacherstrasse 124 CH-4070 Basle, CH
Inventors:
NESTOR, John, Joseph, Jr.; US
USKOKOVIC, Milan, Radoje; US
VICKERY, Brian, Henry; US
Agent:
MAHE, Jean; Grenzacherstrasse 124 CH-4070 Basle, CH
Priority Data:
60/005,96627.10.1995US
Title (EN) PHARMACEUTICAL COMPOSITION FOR TREATING OSTEOPOROSIS
(FR) COMPOSITION PHARMACEUTIQUE DESTINEE AU TRAITEMENT DE L'OSTEOPOROSE
Abstract:
(EN) Pharmaceutical composition for treating osteoporosis or for treating a medical condition characterized by a decrease in bone density, by restoring bone density to an asymptomatic level, without inducing hypercalciuria, hypercalcemia, or nephrotoxicity, said composition containing the compound, 1$g(a)-fluoro-25-hydroxy-16-ene-23-yne-26,27-hexafluorocholecalciferol, as active ingredient.
(FR) Cette composition pharmaceutique est destinée à traiter l'ostéoporose, ou un état médical caractérisé par une chute de la densimétrie osseuse, afin de restaurer cette densimétrie et que celle-ci atteigne un niveau asymptomatique, sans induction d'hypercalciurie, d'hypercalcémie ou de néphrotoxicité, ladite composition contenant en tant que principe actif le composé répondant à la formule 1$g(a)-fluoro-25-hydroxy-16-ène-23-yne-26,27-hexafluorocholécalciférol.
Designated States: AL, AU, BA, BB, BG, BR, CA, CN, CZ, EE, GE, HU, IL, IS, JP, KP, KR, LK, LR, LT, LV, MG, MK, MN, MX, NO, NZ, PL, RO, SG, SI, SK, TR, TT, UA, UZ, VN
African Regional Intellectual Property Organization (ARIPO) (KE, LS, MW, SD, SZ, UG)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, CH, DE, DK, ES, FI, FR, GB, GR, IE, IT, LU, MC, NL, PT, SE)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, ML, MR, NE, SN, TD, TG)
Publication Language: English (EN)
Filing Language: English (EN)
Also published as:
AU1996072956